Wolfgang Sadée

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing

Brian S. Decker, JM Barbarino, JF Peterson et al. · Clinical Pharmacology & Therapeutics · 2015 · 692 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma

Natasha Y. Frank, Armen Margaryan, Ying Huang et al. · Cancer Research · 2005 · 571 citations · Full text

Medicine, Oncology, Pharmacology +16

Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Ying Zhang, Andrew D. Johnson, Audrey C. Papp et al. · Journal of Biological Chemistry · 2005 · 564 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Daqing Wang, Yingying Guo, Steven Wrighton et al. · The Pharmacogenomics Journal · 2010 · 507 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C&gt;T affects mRNA stability

Andrew D. Johnson, Audrey C. Papp, Deanna L. Kroetz et al. · Pharmacogenetics and Genomics · 2005 · 494 citations

Life Sciences, Genetics, Molecular Genetics +14